Discgenics, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2007-11-06
- Employees
- 11
- Market Cap
- -
- Website
- http://www.discgenics.com
Study to Evaluate the Safety and Preliminary Efficacy of IDCT, a Treatment for Symptomatic Lumbar Disc Degeneration
- First Posted Date
- 2019-05-20
- Last Posted Date
- 2022-11-30
- Lead Sponsor
- DiscGenics, Inc.
- Target Recruit Count
- 38
- Registration Number
- NCT03955315
- Locations
- 🇯🇵
Chiba University Hospital, Chuo-ku, Chiba Prefecture, Japan
🇯🇵Tokai University Hospital, Isehara, Kanagawa Prefecture, Japan
🇯🇵University of Yamanashi Hospital, Chuo, Yamanashi Prefecture, Japan
Study to Evaluate the Safety and Preliminary Efficacy of IDCT, a Treatment for Symptomatic Lumbar Intervertebral Disc Degeneration
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2017-11-20
- Last Posted Date
- 2023-01-25
- Lead Sponsor
- DiscGenics, Inc.
- Target Recruit Count
- 60
- Registration Number
- NCT03347708
- Locations
- 🇺🇸
Alabama Clinical Therapeutics, LLC, Birmingham, Alabama, United States
🇺🇸UC San Diego CIRM Alpha Stem Cell Clinic, San Diego, California, United States
🇺🇸Otrimed, Edgewood, Kentucky, United States
© Copyright 2024. All Rights Reserved by MedPath